Sign in
4

Changes in Ownership

BeOne Medicines Ltd. Filed Acc 0001104659-17-010630

Chief Executive Officer sold 64,963 shares at an average $40.55 ($2,634,011)

From the SEC's structured data for this filing

Trades in this filing

OYLER JOHN · Chief Executive Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2017-02-16 Sale : show line 1 in the form −9,057 $40.23 $364,379 378,383 D
2017-02-16 Sale : show line 2 in the form −38,343 $40.75 $1,562,489 340,040 D
2017-02-17 Sale : show line 3 in the form −7,204 $40.67 $292,981 332,836 D
2017-02-21 Sale : show line 4 in the form −7,426 $39.83 $295,794 325,410 D
2017-02-21 Sale : show line 5 in the form −2,933 $40.36 $118,369 322,477 D
Open-market sales · 64,963 sh · avg $40.55 · $2,634,011
Loading xslF345X03/a4.xml…